醫(yī)學(xué)遺傳學(xué) 16腫瘤遺傳學(xué)ppt課件_第1頁
醫(yī)學(xué)遺傳學(xué) 16腫瘤遺傳學(xué)ppt課件_第2頁
醫(yī)學(xué)遺傳學(xué) 16腫瘤遺傳學(xué)ppt課件_第3頁
醫(yī)學(xué)遺傳學(xué) 16腫瘤遺傳學(xué)ppt課件_第4頁
醫(yī)學(xué)遺傳學(xué) 16腫瘤遺傳學(xué)ppt課件_第5頁
已閱讀5頁,還剩58頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

1、Medical GeneticsMedical GeneticsThe ancient Greeks believed that cancer was caused by too much body fluid they called black bile.Medical GeneticsDoctors in the seventeenth and eighteenth centuries suggested that parasites caused cancer. Today, doctors understand more about the link between cancer an

2、d genetics. Medical GeneticsViruses, ultraviolet (UV) radiation, and chemicals can all damage genes in the human body. If particular genes are affected, a person can develop cancer. Understanding how genes cause cancer, though, first requires a basic understanding of several genetic terms and concep

3、ts.Medical GeneticsCancer is a very common disease, affecting about 1 in 3 individuals, and about half the people that contract cancer will die as a direct result of their disease.Medical Genetics For the most part, cancer arises from a single cell, that is, cancer is a clonal disease. The average h

4、uman being contains about 1014 cells (i.e., 100,000,000,000,000 cells), any one of which could, in principle, become a cancer cell, if it acquired the right sort of mutations while it still had the potential to proliferate. Medical Genetics Therefore, the cancer cell arises and progresses once out o

5、f a possible 1014 cellular targets. That only happens in 1 in 3 people. Even then it usually takes 60 or 70 years to occur.Medical GeneticsMedical GeneticsTumors are hereditary Hereditary retinoblastoma is an autosomal dominant trait in which susceptibility to retinoblastoma is inherited. This is an

6、 unusual dominant trait in that a mutation in one RB gene is not sufficient to cause symptoms, but mutations in the second allele often arise during development. Medical GeneticsMedical Genetics Offspring have a 50% chance of receiving the mutant gene from a heterozygous parent, and 90% of carriers

7、will develop retinoblastoma, usually in both eyes. The hereditary form is also associated with a high risk for other cancers especially of the bone and fibrous tissues (osteosarcomas and fibrosarcoma.Medical Genetics Sporadic retinoblastoma is a trait in which the affected individual has not inherit

8、ed any mutant alleles of the retinoblastoma gene. Medical Genetics The mutations occur after birth and result in tumor formation. Tumors usually develop in only one eye and patients are not at high risk for other cancers. Both alleles need to be mutated in a single cell, and that is why this form ty

9、pically occurs only in one eye.Medical GeneticsMedical GeneticsChromosome and tumors Detailed studies of the Philadelphia chromosome show that most of chromosome 22 has been translocated onto the long arm of chromosome 9. In addition, the small distal portion of the short arm of chromosome 9 is tran

10、slocated to chromosome 22. This translocation, which is found only in tumor cells, indicates that a patient has chronic myelogenous leukemia (CML). In CML, the cells that produce blood cells for the body (the hematopoietic cells) grow uncontrollably, leading to cancer. Medical GeneticsMedical Geneti

11、csMedical Genetics The connection between this chromosomal abnormality and CML was clarified by studying the genes located on the chromosomes at the sites of the translocation breakpoints. Medical Genetics In one of the translocated chromosomes, part of a gene called abl is moved from its normal loc

12、ation on chromosome 9 to a new location on chromosome 22. This breakage and reattachment leads to an altered abl gene. The protein produced from the mutant abl gene functions improperly, leading to CML.Medical Genetics Oncogenes are mutated forms of genes that cause normal cells to grow out of contr

13、ol and become cancer cells. They are mutations of certain normal genes of the cell called proto-oncogenes. Medical Genetics Proto-oncogenes are the genes that normally control how often a cell divides and the degree to which it differentiates (or specializes). When a proto-oncogene mutates (changes)

14、 into an oncogene, it becomes permanently turned on or activated when it is not supposed to be. When this occurs, the cell divides too quickly, which can lead to cancer. Medical Genetics It may be helpful to think of a cell as a car. For it to work properly, there need to be ways to control how fast

15、 it goes. A proto-oncogene normally functions in a way that is similar to a gas pedal - it helps the cell grow and divide. An oncogene could be compared to a gas pedal that is stuck down, which causes the cell to divide out of control. Medical Genetics The pathway for normal cell growth starts with

16、growth factor, which locks onto a growth factor receptor. The signal from the receptor is sent through a signal transducer. A transcription factor is produced, which causes the cell to begin dividing. If any abnormality is detected, the cell is made to commit suicide by a programmed cell death regul

17、ator. Medical Genetics More than 100 oncogenes are now recognized, and undoubtedly more will be discovered in the future. Scientists have divided oncogenes into the 5 different classes.Medical GeneticsGrowth factors These oncogenes produce factors that stimulate cells to grow. The best known of thes

18、e is called sis. It leads to the overproduction of a protein called platelet-derived growth factor, which stimulates cells to grow. Medical GeneticsGrowth factor receptors These are normally turned on or off by growth factors. When they are on, they stimulate the cell to grow. Certain mutations in t

19、he genes that produce these cause them to always be on. In other cases, the genes are amplified. Medical Genetics This means that instead of the usual 2 copies of the gene, there may be several extras, resulting in too many growth factor receptor molecules. As a result, the cells become overly sensi

20、tive to growth-promoting signals. Medical Genetics The best known examples of growth factor receptor gene amplification are erb B and erb B-2. These are sometimes known as epidermal growth factor receptor and HER2/neu. HER2/neu gene amplification is an important abnormality seen in about one third o

21、f breast cancers. Both of these oncogenes are targets of newly developed anti-cancer treatments. Medical GeneticsSignal transducers These are the intermediate pathways between the growth factor receptor and the cell nucleus where the signal is received. Like growth factor receptors, these can be tur

22、ned on or off. When they are abnormal in cancer cells, they are turned on. Medical GeneticsTranscription factors These are the final molecules in the chain that tell the cell to divide. These molecules act on the DNA and control which genes are active in producing RNA and protein. Medical Genetics T

23、he best known of these is called myc. In lung cancer, leukemia, lymphoma, and a number of other cancer types, myc is often overly activated and stimulates cell division. Medical Genetics Two well known signal transducers are abl and ras. Abl is activated in chronic myelocytic leukemia and is the tar

24、get of the most successful drug for this disease, imatinib or Gleevec. Abnormalities of ras are found in many cancers. Medical GeneticsProgrammed cell death regulators These molecules prevent a cell from committing suicide when it becomes abnormal. When these genes are overactive they prevent the ce

25、ll from going through the suicide process. Medical Genetics This leads to an overgrowth of abnormal cells, which can then become cancerous. The most well described one is called bcl-2. It is often activated in lymphoma cells. Medical Genetics Tumor suppressor genes are normal genes that slow down ce

26、ll division, repair DNA mistakes, and tell cells when to die (a process known as apoptosis or programmed cell death). Medical Genetics When tumor suppressor genes do work properly, cells can grow out of control, which can lead to cancer. About 30 tumor suppressor genes have been identified, includin

27、g p53, BRCA1, BRCA2, APC, and RB1. Some of these will be described in more detail later on. Medical Genetics A tumor suppressor gene is like the brake pedal on a car it normally keeps the cell from dividing too quickly just as a brake keeps a car from going too fast. When something goes wrong with t

28、he gene, such as a mutation, cell division can get out of control. Medical Genetics An important difference between oncogenes and tumor suppressor genes is that oncogenes result from the activation (turning on) of proto-oncogenes, but tumor suppressor genes cause cancer when they are inactivated (tu

29、rned off). Medical Genetics Another major difference is that while the overwhelming majority of oncogenes develop from mutations in normal genes (proto-oncogenes) during the life of the individual (acquired mutations), abnormalities of tumor suppressor genes can be inherited as well as acquired. Med

30、ical GeneticsTypes of Tumor Suppressor Genes Genes that control cell divisionGenes that repair DNA Cell suicide genes Medical GeneticsGenes that control cell division Some tumor suppressor genes help control cell growth and reproduction. The RB1 (retinoblastoma) gene is an example of such a gene. Ab

31、normalities of the RB1 gene can lead to a type of eye cancer (retinoblastoma) in infants, as well as to other cancers. Medical GeneticsGenes that repair DNA A second group of tumor suppressor genes is responsible for repairing DNA damage. Every time a cell prepares to divide into 2 new cells, it mus

32、t duplicate its DNA. Medical Genetics This process is not perfect, and copying errors sometimes occur. Fortunately, cells have DNA repair genes, which make proteins that proofread DNA. But if the genes responsible for the repair are faulty, then the DNA can develop abnormalities that may lead to can

33、cer. Medical Genetics When DNA repair genes do work, mutations can slip by, allowing oncogenes and abnormal tumor suppressor genes to be produced. The genes responsible for HNPCC (hereditary nonpolyposis colon cancer) are examples of DNA repair gene defects. When these genes do not repair the errors

34、 in DNA, HNPCC can result. HNPCC accounts for up to 5% of all colon cancers and some endometrial cancers. Medical GeneticsCell suicide genes If there is too much damage to a cell DNA to be fixed by the DNA repair genes, the p53 tumor suppressor gene is responsible for destroying the cell by a proces

35、s sometimes described as cell suicide.Medical Genetics Other names for this process are programmed cell death or apoptosis. If the p53 gene is not working properly, cells with DNA damage that has not been repaired continue to grow and can eventually become cancerous. Medical Genetics Abnormalities o

36、f the p53 gene are sometimes inherited, such as in the Li-Fraumeni syndrome (LFS). People with LFS have a higher risk for developing a number of cancers, including soft-tissue and bone sarcomas, brain tumors, breast cancer, adrenal gland cancer, and leukemia. Medical Genetics Many sporadic (not inhe

37、rited) cancers such as lung cancers, colon cancers, breast cancers as well as others often have mutated p53 genes within the tumor. Medical GeneticsInherited Abnormalities of Tumor Suppressor Genes Inherited abnormalities of tumor suppressor genes have been found in several cancers that tend to run

38、in families. Medical Genetics In addition to mutations in p53, RB1, and the genes involved in HNPCC, several other mutations in tumor suppressor genes can be inherited. Medical Genetics A defective APC gene causes familial polyposis, a condition in which people develop hundreds or thousands of colon

39、 polyps, some of which may eventually acquire several sporadic mutations and turn into colon cancer. Medical Genetics Abnormalities of the BRCA genes account for 5% to 10% of breast cancers. There are also many other examples of inherited tumor suppressor gene mutations, and more are being discovere

40、d each year. Medical GeneticsNon-inherited mutations of tumor suppressor genes Mutations of tumor suppressor genes have been found in many cancers. Medical Genetics For example, abnormalities of the p53 gene have been found in over 50% of human cancers. Acquired mutations (those which happen during

41、a person life) of the p53 gene appear to be involved in a wide range of cancers, including lung, colorectal, and breast cancer, as well as many others. Medical Genetics The p53 gene is believed to be among the most frequently mutated genes in human cancer. However, acquired changes in many other tum

42、or suppressor genes also contribute to the development of sporadic (not inherited) cancers.Medical GeneticsInherited cancer Abnormal gene Other non-inherited cancers seen with this geneRetinoblastomaRBIMany different cancers Li-Fraumeni Syndrome (sarcomas, brain tumors, leukemia)P53Many different cancersMel

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論